FDA Drug Recalls

Recalls / Generics / Temozolomide

Temozolomide

7 FDA drug recalls involving generic “Temozolomide”.

DateClassProductFirm
2026-03-03Class IIProduct label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising PhRising Pharma Holding, Inc.
2019-07-16Class IITemozolomide Capsules, 20 mg, packaged in a) 5-count bottle (NDC 67877-538-07), b) 14-count bottle (NDC 67877-Deva Holding AS - Cerkezkoy Subesi
2019-07-16Class IITemozolomide Capsules, 180 mg, packaged in a) 5-count bottle (NDC 67877-541-07), b) 14-count bottle (NDC 67877Deva Holding AS - Cerkezkoy Subesi
2019-07-16Class IITemozolomide Capsules, 100 mg, packaged in a) 5-count bottle (NDC 67877-539-07), b) 14-count bottle (NDC 67877Deva Holding AS - Cerkezkoy Subesi
2019-07-16Class IITemozolomide Capsules, 140 mg, packaged in a) 5-count bottle (NDC 67877-540-07), b) 14-count bottle (NDC 67877Deva Holding AS - Cerkezkoy Subesi
2019-07-16Class IITemozolomide Capsules, 250 mg, 5-count bottle, Rx only, Manufactured by: Deva Holding A.S., 1 Merkez MahallesiDeva Holding AS - Cerkezkoy Subesi
2019-07-16Class IITemozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 67877-537-07), b) 14-count bottle (NDC 67877-5Deva Holding AS - Cerkezkoy Subesi